Medicare Enrolled

Dr. Anish Patel, D.O.

Gastroenterology · Fort Sam Houston, TX
3551 ROGER BROOKE DR, Fort Sam Houston, TX 78234
2109163647
Registered in NPPES since 2007
NPI: 1649476466 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Anish Patel is a gastroenterology specialist in Fort Sam Houston, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Patel received a total of $981,222 from 32 pharmaceutical and/or device companies across 1100 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $981,222 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$981,222
Total received (2018-2024)
Avg $140,175/year across 7 years
Top 0% in TX for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
1,100
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$306,514
2023
$149,733
2022
$219,098
2021
$101,109
2020
$20,954
2019
$90,737
2018
$93,077

Payments by company (2024)

Janssen Biotech, Inc.
$109,307
Takeda Pharmaceuticals U.S.A., Inc.
$79,193
Lilly USA, LLC
$54,271
E.R. Squibb & Sons, L.L.C.
$23,344
Phathom Pharmaceuticals, Inc.
$22,689
PFIZER INC.
$14,483
ABBVIE INC.
$2,007
Celgene Corporation
$905
Regeneron Healthcare Solutions, Inc.
$194
GENZYME CORPORATION
$49
IRONWOOD PHARMACEUTICALS, INC
$26
Merck Sharp & Dohme LLC
$24
QOL Medical, LLC
$21
Top 3 companies account for 79.2% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$368,985
E.R. Squibb & Sons, L.L.C.
$180,410
Janssen Biotech, Inc.
$169,951
Janssen Scientific Affairs, LLC
$90,519
Lilly USA, LLC
$65,644
Daiichi Sankyo Inc.
$27,723
Phathom Pharmaceuticals, Inc.
$22,689
PFIZER INC.
$14,918
Prometheus Laboratories Inc.
$13,938
ABBVIE INC.
$6,542
Celgene Corporation
$6,317
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$3,876
AbbVie Inc.
$3,005
Gilead Sciences, Inc.
$2,680
AbbVie, Inc.
$1,811
Boston Scientific Corporation
$300
Romark Laboratories, LC
$300
Regeneron Healthcare Solutions, Inc.
$300
Laborie Medical Technologies Corp.
$210
American Regent
$195
Medtronic, Inc.
$170
Olympus America Inc.
$139
Shire North American Group Inc
$123
GENZYME CORPORATION
$114
Covidien LP
$104
ERBE USA Inc
$81
Fresenius Kabi USA, LLC
$53
Intercept Pharmaceuticals, Inc.
$40
IRONWOOD PHARMACEUTICALS, INC
$26
Merck Sharp & Dohme LLC
$24
QOL Medical, LLC
$21
PORTOLA PHARMACEUTICALS, INC.
$14
Top 3 companies account for 73.3% of all-time payments
Associated products mentioned in payments ›
Alinia Tablets 500mg 30 count bottle · BEVYXXA · Barrx · CREON · Creon · DISPOSABLE EMR KIT · DISPOSABLE TRIPLE LUMEN SPHINCTEROTOME · DUPIXENT · ENTYVIO · EXALT Model D · Entyvio · Erbe VIO3 APC3 · GATTEX · HUMIRA · Humira · IDACIO · INJECTAFER · LINZESS · Linzess · MAVYRET · MOUNJARO · OCALIVA · OMVOH · Ozanimod · PillCam · REMICADE · RINVOQ · SKYRIZI · STELARA · SUCRAID · SmartPill · TREMFYA · VELSIPITY · VOQUEZNA · XELJANZ · XIFAXAN · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gastroenterology specialist in Fort Sam Houston?
Compare gastroenterologists in the Fort Sam Houston area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists in nearby ZIP areas
103
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
Brooke Army Medical Center (FT Sam Houston)
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a gastroenterology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $981,222 from 32 companies across 1,100 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Fort Sam Houston
Browse gastroenterologists in Fort Sam Houston ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in TX
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in TX
Which TX gastroenterologists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →